Acción A950130 ACCESS BIO, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Access Bio, Inc.

Acciones

A950130

KR8840090003

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 20/06/2024 		Varia. Cinco días. Varia. 1 de enero.
6.760 KRW -0,15 % Gráfico intradía de Access Bio, Inc. +1,50 % -24,64 %
2023 Access Bio, Inc. (KOSDAQ:A950130) adquirió una participación minoritaria desconocida en CuraPatient Inc. CI
2023 Access Bio, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc.
Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.
Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.
Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.
Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.
Access Bio, Inc. agreed to acquire Belight Investment for approximately KRW 130 billion.
Access Bio, Inc's Equity Buyback announced on March 24, 2022, has expired with 1,840,483 shares, representing 5.22% for KRW 29,899.64 million.
Access Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Access Bio, Inc.'s Equity Buyback Plan Extended till May 23, 2023.
AirBoss Defense Group and Maddox Defense Partner With Access Bio to Deliver US-Made COVID Test Kits to Defense Logistics Agency; BOS Up 2.6%
AirBoss Defense Group and Maddox Defense Partner With Access Bio to Deliver US-Made COVID Test Kits to Defense Logistics Agency
AirBoss of America Brief: Defense Logistics Agency has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to US$410 Million to Access Bio
AirBoss of America Brief: AirBoss Defense Group and Maddox Defense Partner With Access Bio to Deliver US-Made COVID Test Kits to Defense Logistics Agency
QuidelOrtho, Orasure Technologies, Others Share $803 Million Contract From US Defense Logistics Agency
Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.
Wellysis announced that it has received KRW 5 billion in funding from Access Bio, Inc.
Access Bio, Inc. announces an Equity Buyback for KRW 30,000 million worth of its shares.
Access Bio, Inc. authorizes a Buyback Plan.
Access Bio, Inc. announced that it has received KRW 30 billion in funding from Meritz Securities Co., Ltd.
Access Bio, Inc. announced that it expects to receive KRW 30 billion in funding from Meritz Securities Co., Ltd.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A950130
  4. Noticias Access Bio, Inc.
  5. Otros idiomas